<DOC>
	<DOCNO>NCT00901784</DOCNO>
	<brief_summary>The objective study compare single-dose relative bioavailability Ranbaxy Ortho-McNeil Pharmaceutical ( Topamax® ) 25 mg topiramate tablet follow 50 mg dose fasting condition .</brief_summary>
	<brief_title>Bioequivalence Study Topiramate Tablets 25mg Under Fasting Conditions</brief_title>
	<detailed_description>This open-label , randomize , single-dose , 2-way crossover , relative bioavailability study perform 24 healthy adult male volunteer 4 alternate . All 28 subject complete clinical phase study . In period , subject house even dose 24-hour blood draw . Subjects return 48- , 72- , 96- 120-hour blood draw . Both period separate washout period 14 day .</detailed_description>
	<mesh_term>Topiramate</mesh_term>
	<criteria>1 . This study involve healthy adult male volunteer , 1845 year age , weigh least 52 kg , within 15 % ideal weight ( Table `` Desirable Weights Adults '' , Metropolitan Life Insurance Company , 1983 ) . 2 . Only medically healthy subject clinically normal laboratory profile enrol study . 1 . History presence significant : • cardiovascular , pulmonary , hepatic , renal , hematologic , gastrointestinal , endocrine , immunologic , dermatologic , neurologic psychiatric disease . In addition , history presence : Hypersensitivity idiosyncratic reaction topiramate Nephrolithiasis gout Alcoholism drug abuse within past year 2 . Subjects abnormal diet ( whatever reason ) 28 day precede study . 3 . Subjects drug substance know strong inhibitor CYP ( cytochrome P450 ) enzymes within 10 day study start . 4 . Subjects use drug substance know strong inducer CYP ( cytochrome P450 ) enzymes within 28 day study start . 5 . Subjects , completion study , would donate excess : 500 mL blood 14 day , 500750 mL blood 14 day ( unless approve Principal Investigator ) , 1000 mL blood 90 day , 1250 mL blood 120 day , 1500 mL blood 180 day , 2000 mL blood 270 day , 2500 mL blood 1 year , 6 . Subjects participate another clinical trial within 28 day study start .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>Topiramate fasting study</keyword>
</DOC>